Intrexon (XON) Scheduled to Post Earnings on Tuesday

Intrexon (NYSE:XON) is scheduled to be releasing its earnings data after the market closes on Tuesday, February 27th. Analysts expect Intrexon to post earnings of ($0.32) per share for the quarter.

Intrexon (NYSE XON) opened at $13.25 on Tuesday. The company has a quick ratio of 1.85, a current ratio of 2.05 and a debt-to-equity ratio of 0.01. Intrexon has a fifty-two week low of $10.26 and a fifty-two week high of $26.99. The company has a market cap of $1,680.00, a price-to-earnings ratio of -11.83 and a beta of 1.40.

In related news, CEO Randal J. Kirk acquired 1,000,000 shares of the company’s stock in a transaction dated Friday, January 19th. The stock was bought at an average cost of $12.50 per share, with a total value of $12,500,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 56.30% of the company’s stock.

Several brokerages have commented on XON. Stifel Nicolaus raised their price target on shares of Intrexon from $39.00 to $57.00 and gave the company a “buy” rating in a report on Friday, November 10th. Zacks Investment Research raised shares of Intrexon from a “sell” rating to a “hold” rating in a report on Monday, January 22nd. ValuEngine downgraded shares of Intrexon from a “sell” rating to a “strong sell” rating in a report on Friday, February 2nd. Bank of America dropped their price objective on shares of Intrexon from $25.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, November 10th. Finally, Northland Securities reaffirmed a “buy” rating and set a $21.00 price objective on shares of Intrexon in a report on Friday, November 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company. Intrexon currently has an average rating of “Hold” and a consensus price target of $38.50.

TRADEMARK VIOLATION NOTICE: “Intrexon (XON) Scheduled to Post Earnings on Tuesday” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at

About Intrexon

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Earnings History for Intrexon (NYSE:XON)

Receive News & Ratings for Intrexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply